Publications database

Contingency management is a general behavioural intervention technique used in the treatment of drug dependence. This EMCDDA Paper contains a systematic review of studies on the effectiveness of contingency management when used...

This report presents the most recent and comprehensive data on substance use among 15- to 16-year-old school students in Europe. Based on the responses from over 90 000 girls and boys, the...

This brochure provides an overview of the 2015 ESPAD Report which the EMCDDA co-produced with ESPAD.

This brochure offers an overview of the latest EU Drug Markets Report, from the EMCDDA and Europol. Published every three years, the report provides a state-of-the-art analysis of the illicit drug market...

This rapid communication provides an update on drug related hospital emergency presentations in Europe with a specific focus on the latest results for acute drug toxicity presentations to the European Drug Emergencies...

Hepatitis C among drug users in Europe: epidemiology, treatment and prevention provides a timely contribution to raising awareness of the hepatitis C epidemic in Europe and the opportunities now opening up to...

This publication presents the data and findings of the risk assessment on α-PVP (1-phenyl- 2-(1-pyrrolidinyl)-1-pentanone), carried out by the extended Scientific Committee of the EMCDDA on 18 November 2015. α-PVP is the...

This report presents the key activities performed by the EMCDDA and Europol in 2015 and the results of the implementation of Council Decision 2005/387/JHA on the information exchange, risk assessment and control...

In February 2016, the EMCDDA and Europol examined the available information on a new psychoactive substance methyl 2-[[1-(cyclohexylmethyl)indole-3-carbonyl]amino]-3,3-dimethylbutanoate, commonly known as MDMB-CHMICA, through a joint assessment. The two organisations concluded that sufficient...

These are the EMCDDA's final annual accounts for the financial year 2015.